UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act File Number: 811-04519
T. Rowe Price Capital Appreciation Fund |
|
(Exact name of registrant as specified in charter) |
|
100 East Pratt Street, Baltimore, MD 21202 |
|
(Address of principal executive offices) |
|
David Oestreicher |
100 East Pratt Street, Baltimore, MD 21202 |
|
(Name and address of agent for service) |
Registrant’s telephone number, including area code: (410) 345-2000
Date of fiscal year end: December 31
Date of reporting period: December 31, 2015
Item 1. Report to Shareholders
Capital Appreciation Fund | December 31, 2015 |
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx2x1.jpg)
The views and opinions in this report were current as of December 31, 2015. They are not guarantees of performance or investment results and should not be taken as investment advice. Investment decisions reflect a variety of factors, and the managers reserve the right to change their views about individual stocks, sectors, and the markets at any time. As a result, the views expressed should not be relied upon as a forecast of the fund’s future investment intent. The report is certified under the Sarbanes-Oxley Act, which requires mutual funds and other public companies to affirm that, to the best of their knowledge, the information in their financial reports is fairly and accurately stated in all material respects.
REPORTS ON THE WEB
Sign up for our E-mail Program, and you can begin to receive updated fund reports and prospectuses online rather than through the mail. Log in to your account at troweprice.com for more information.
Manager’s Letter
Fellow Shareholders
In 2015, the U.S. equity and fixed income markets generated very modest returns. The S&P 500 Index returned 1.38% for the full year as earnings growth stagnated from a combination of lower oil prices, a strong dollar, and further slowing in emerging markets. While low oil prices are clearly a benefit for the U.S. and global consumer, they are not a net benefit to corporate earnings, at least not in the short term. Moreover, it appears that the U.S. consumer ended up saving the majority of the benefit from lower gasoline prices and paying down debt instead of spending the windfall.
The U.S. fixed income market, using the Barclays U.S. Aggregate Bond Index as a proxy, was up a meager 0.55% as interest rates rose modestly and investment-grade credit spreads expanded. Investment-grade credit spreads rose principally due to weakening fundamentals within energy, energy-related, and metals firms. This weakness was even more extreme in the U.S. high yield market as lower-quality energy companies with too much debt were ill-prepared for a sub-$70 oil environment. As a result, we believe there will be a wave of bankruptcies in lower-quality energy and metals companies in the coming one to two years in the noninvestment-grade market. While the metals and energy sectors represent only about 20% of the high yield universe, and while these sectors have been hit the hardest, the technical selling pressure and risk-off attitude toward the asset class have created some very compelling opportunities within the highest-quality spectrum of the high yield market. We love to invest in asset classes where panicking investors are “throwing the baby out with the bathwater,” and there is no better example in today’s market than what is happening within the higher-quality spectrum of the high yield markets.
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx3x1.jpg)
While your fund has been consistently underweight equities for the last couple of years due to elevated valuations, irrational euphoria in parts of the market, and decelerating earnings growth (which will likely be close to 0% in 2015), the equity market correction at the start of 2016 is beginning to produce some interesting opportunities. While we remain underweight equities, this underweight is starting to shrink as we find more attractive risk/reward investment opportunities in both equity and fixed income markets. We are hopeful that this correction will provide us with an opportunity to lower our substantial cash reserves.
Before we discuss fund performance, I would like to review the three goals of the Capital Appreciation Fund:
(1) Generate strong risk-adjusted returns annually
(2) Preserve shareholder capital over the intermediate term (i.e., three years)
(3) Generate equity-like returns with less risk than that of the overall market over a full market cycle (i.e., normally five years)
We are pleased to report that the Capital Appreciation Fund generated solid investment performance despite being conservatively positioned. For 2015, your fund generated a 5.42% return versus the S&P 500’s 1.38% return. (The performance of the Advisor Class was slightly lower, reflecting a different fee structure.)
Your fund outperformed the market on a risk-adjusted basis over this period, generating 393% of the market’s return while only taking on 61% of the market’s risk. We arrived at this risk number by comparing the standard deviation of the S&P 500 (15.46) with that of the fund (9.43) for the 12-month period. Standard deviation indicates the volatility of a portfolio’s total returns as measured against its mean performance. In general, the higher the standard deviation, the greater the volatility or risk.
Using a more academic measure of the fund’s risk-adjusted return, your fund produced a Sharpe ratio of 0.57 versus 0.09 for the S&P 500. The Sharpe ratio is a measure of the risk-adjusted return of a portfolio. It measures how much a portfolio’s return is above or below the risk-free Treasury rate (excess return) per unit risk (measured by standard deviation). In general, the larger the number, the better the portfolio’s historical risk-adjusted return.
As for our second goal—capital preservation over the intermediate term—your fund generated a 44.88% cumulative return over the last three years. This has been a relatively simple goal to achieve given how strong equity market returns have been over this time period.
As for our final goal—equity-like returns with less risk than the market over a full market cycle—your fund generated a 71.48% cumulative return over the last five years versus 80.75% for the S&P 500. Based on annualized returns of 11.39% for your fund versus 12.57% for the S&P 500—your fund generated 91% of the market’s return over the last five years while taking on 65% of the market’s risk. While market and economic cycles historically have lasted around five years on average, we also tend to think about a full market cycle encompassing at least one ugly return year. As your fund is not a pure equity fund, it would be very difficult to match the equity market returns over any period in which we did not have at least one equity market correction. Hence, if we were to extend the analysis to encompass 2008 and measure the last eight years of performance, we would have accomplished this last goal by delivering 128% of the market’s return over this period while only taking on 70% of the market’s risk.
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx5x1.jpg)
For the six-month and 1-, 3-, 5-, and 10-year periods ended December 31, 2015, we outperformed our Lipper and Morningstar peers over every period. However, let me reiterate that we do not manage your fund to beat these benchmarks. The Capital Appreciation Fund has very different objectives than most of its benchmark peers. It is a unique fund with a clear focus on strong risk-adjusted returns, intermediate-term capital preservation, and long-term capital appreciation that does not neatly fit into any current benchmark.
Within the equity portion of the portfolio, our health care holdings were the strongest contributors to both absolute and relative returns in 2015. Thermo Fisher Scientific, Cigna, and Eli Lilly were all important contributors to performance. Thermo Fisher Scientific performed well despite significant foreign exchange headwinds to its earnings as organic growth was stable and the top- and bottom-line benefits from the Life Technologies acquisition were better than expected. In addition, a year-end budget deal that expanded the National Institutes of Health’s (NIH’s) budget for 2016 should be a benefit for Thermo’s sales into this important end market. We continue to have a large position in Thermo Fisher Scientific. Cigna outperformed after Anthem agreed to acquire it for a large premium. Eli Lilly outperformed as the market became more excited about its Alzheimer’s pipeline as well as good trial results from a diabetes product. We no longer own Cigna or Eli Lilly as both stocks hit our price targets and the risk/reward trade-offs were no longer compelling. In aggregate, we have modestly reduced our health care weight as valuations in the space have risen and political risk has increased. (Please refer to the fund’s portfolio of investments for a complete list of holdings and the amount each represents in the portfolio.)
Our holdings in the information technology sector were also strong contributors to both absolute and relative returns. One of our largest holdings, Fiserv, was a principal contributor to these strong results. In an environment with rising foreign exchange headwinds, weak oil prices, decelerating earnings growth, and emerging market disappointments, Fiserv did extremely well as it is generally insulated from these pressures, and its fundamentals strengthened from an organic top- and bottom-line perspective in 2015. The company has continued to aggressively buy back its shares, improve margins, and be disciplined on acquisitions. Very much like Thermo Fisher Scientific, we view Fiserv as a core position in your fund. In addition to Fiserv, Microsoft and Visa were strong absolute and relative performers within the information technology sector.
Our investments within the consumer discretionary sector detracted from relative performance, primarily due to the underperformance of Johnson Controls. We are perplexed by the valuation of Johnson Controls and its performance in 2015. This is a company that has done just about everything right operationally and strategically since we bought the stock a couple of years ago. New management has improved margins in all three of its businesses, bought back stock at depressed prices, and even made the very shareholder-friendly decision to separate the lower-growth automotive business from the faster-growth, less cyclical power solutions and building efficiency businesses. Despite solid operational execution and strong earnings growth, the stock has languished due to concerns about the macro environment in China and recent weakness in automotive sales in North America and some concern about a slowing nonresidential construction environment. With Johnson Controls’ absolute and relative valuation at multiyear lows and the catalyst of the automotive spinoff happening later this year, we think that the risk/reward trade-off is compelling even if the macro environment has a modest negative impact on near-term fundamentals. Johnson Controls is one of our largest bets in the fund, and it is one we feel very good about both in the near term and the long term.
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx7x1.jpg)
Our fixed income investments modestly outperformed the Barclays U.S. Aggregate Bond Index. Frankly, we were somewhat surprised by this, as well over half of our fixed income investments are noninvestment grade and the overall noninvestment-grade index was down mid-single digits in 2015, due to weakness in commodity end markets. We were able to generate positive fixed income returns by investing in the highest-quality noninvestment-grade debt and by avoiding the temptation to sacrifice quality for near-term juicy yields. We continue to see very good absolute and relative value within parts of the noninvestment-grade market. The higher-quality end of the noninvestment-grade market appears to offer the most attractive risk/reward trade-offs within any asset class in which we can invest, with limited intermediate-term downside and very solid intermediate-term upside potential. We hope to take advantage of this opportunity.
PORTFOLIO STRATEGY AND OUTLOOK
In past letters, we have written about our dual responsibilities to our shareholders: capital appreciation and capital preservation. During periods of positive sentiment, high valuations, and fewer attractive risk/reward opportunities, you should expect us to favor capital preservation. We have prioritized capital preservation for much of the last two years as we have been underweight equities. However, during periods of market stress, when heightened uncertainty causes valuations to contract and the market sours on risk assets, you should expect us to begin to rebalance our priorities toward capital appreciation. Buying into uncertainty during periods of market stress in late 2008; in August and September 2011; and, more recently, in August 2015 (briefly) has created significant value for long-term shareholders, even if it adds to volatility in the short term.
To the extent that the equity and noninvestment-grade debt markets continue to sell off and produce more attractive investment opportunities for us to deploy our shareholders’ assets into, rest assured that we will seek to take advantage of those opportunities. However, you can also rest assured that our goal of preserving shareholder capital over a three-year period will continue to dominate our analysis and investment decisions. One of the fundamental truths that the market fails to grasp is that the lower valuations go, and the cheaper these assets become, the lower the risk of loss over the intermediate term. In fact, the period in which the risk of loss is greatest is during those euphoria periods when valuations are high (significant valuation downside), sentiment is positive (and can only get worse), and the future seems bright (the future is far more uncertain than the market understands).
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx8x1.jpg)
IN CLOSING
We would like to thank the members of the fund’s Investment Advisory Committee for their valuable input throughout 2015. This team, which comprises portfolio managers, quantitative analysts, fixed income analysts, associate analysts, and equity analysts with many decades of combined investment experience, is responsible for the oversight of your fund and is supported by a growing equity and fixed income platform of more than 200 analysts.
Respectfully submitted,
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx9x1.jpg)
David R. Giroux
Chairman of the fund’s Investment Advisory Committee
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx9x2.jpg)
Steven D. Krichbaum
Associate portfolio manager
January 22, 2016
The committee chairman has day-to-day responsibility for managing the portfolio and works with committee members in developing and executing the fund’s investment program.
RISKS OF INVESTING
As with all stock and bond mutual funds, the fund’s share price can fall because of weakness in the stock or bond markets, a particular industry, or specific holdings. Stock markets can decline for many reasons, including adverse political or economic developments, changes in investor psychology, or heavy institutional selling. The prospects for an industry or company may deteriorate because of a variety of factors, including disappointing earnings or changes in the competitive environment. In addition, the investment manager’s assessment of companies held in a fund may prove incorrect, resulting in losses or poor performance even in rising markets. A sizable cash or fixed income position may hinder the fund from participating fully in a strong, rapidly rising bull market. In addition, significant exposure to bonds increases the risk that the fund’s share value could be hurt by rising interest rates or credit downgrades or defaults. Convertible securities are also exposed to price fluctuations of the company’s stock.
GLOSSARY
Lipper indexes: Fund benchmarks that consist of a small number of the largest mutual funds in a particular category as tracked by Lipper Inc.
Morningstar Moderate Allocation Average: Tracks the performance of funds that seek both moderate capital appreciation and income by investing in stocks, bonds, and cash.
Sharpe ratio: A measure of the risk-adjusted return of a portfolio. The Sharpe ratio measures how much a portfolio’s return is above or below the risk-free Treasury rate (excess return) per unit risk (measured by standard deviation). In general, the larger the number, the better the portfolio’s historical risk-adjusted return.
S&P 500 Index: An unmanaged index that tracks the stocks of 500 primarily large-cap U.S. companies.
Standard deviation: A measure of risk that indicates the volatility of a portfolio’s total returns as measured against its mean performance. In general, the higher the standard deviation, the greater the volatility or risk.
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx11x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx12x1.jpg)
Performance and Expenses
This chart shows the value of a hypothetical $10,000 investment in the fund over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The result is compared with benchmarks, which may include a broad-based market index and a peer group average or index. Market indexes do not include expenses, which are deducted from fund returns as well as mutual fund averages and indexes.
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx13x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx13x2.jpg)
As a mutual fund shareholder, you may incur two types of costs: (1) transaction costs, such as redemption fees or sales loads, and (2) ongoing costs, including management fees, distribution and service (12b-1) fees, and other fund expenses. The following example is intended to help you understand your ongoing costs (in dollars) of investing in the fund and to compare these costs with the ongoing costs of investing in other mutual funds. The example is based on an investment of $1,000 invested at the beginning of the most recent six-month period and held for the entire period.
Please note that the fund has three share classes: The original share class (Investor Class) charges no distribution and service (12b-1) fee, the Advisor Class shares are offered only through unaffiliated brokers and other financial intermediaries and charge a 0.25% 12b-1 fee, and I Class shares are available to institutionally oriented clients and impose no 12b-1 or administrative fee payment. Each share class is presented separately in the table.
Actual Expenses
The first line of the following table (Actual) provides information about actual account values and expenses based on the fund’s actual returns. You may use the information on this line, together with your account balance, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number on the first line under the heading “Expenses Paid During Period” to estimate the expenses you paid on your account during this period.
Hypothetical Example for Comparison Purposes
The information on the second line of the table (Hypothetical) is based on hypothetical account values and expenses derived from the fund’s actual expense ratio and an assumed 5% per year rate of return before expenses (not the fund’s actual return). You may compare the ongoing costs of investing in the fund with other funds by contrasting this 5% hypothetical example and the 5% hypothetical examples that appear in the shareholder reports of the other funds. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period.
Note: T. Rowe Price charges an annual account service fee of $20, generally for accounts with less than $10,000. The fee is waived for any investor whose T. Rowe Price mutual fund accounts total $50,000 or more; accounts electing to receive electronic delivery of account statements, transaction confirmations, prospectuses, and shareholder reports; or accounts of an investor who is a T. Rowe Price Preferred Services, Personal Services, or Enhanced Personal Services client (enrollment in these programs generally requires T. Rowe Price assets of at least $100,000). This fee is not included in the accompanying table. If you are subject to the fee, keep it in mind when you are estimating the ongoing expenses of investing in the fund and when comparing the expenses of this fund with other funds.
You should also be aware that the expenses shown in the table highlight only your ongoing costs and do not reflect any transaction costs, such as redemption fees or sales loads. Therefore, the second line of the table is useful in comparing ongoing costs only and will not help you determine the relative total costs of owning different funds. To the extent a fund charges transaction costs, however, the total cost of owning that fund is higher.
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx15x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx16x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx17x1.jpg)
The accompanying notes are an integral part of these financial statements.
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx18x1.jpg)
The accompanying notes are an integral part of these financial statements.
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx19x1.jpg)
The accompanying notes are an integral part of these financial statements.
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx20x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx21x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx22x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx23x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx24x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx25x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx26x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx27x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx28x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx29x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx30x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx31x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx32x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx33x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx34x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx35x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx36x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx37x1.jpg)
The accompanying notes are an integral part of these financial statements.
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx38x1.jpg)
The accompanying notes are an integral part of these financial statements.
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx40x1.jpg)
The accompanying notes are an integral part of these financial statements.
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx42x1.jpg)
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx43x1.jpg)
The accompanying notes are an integral part of these financial statements.
Notes to Financial Statements |
T. Rowe Price Capital Appreciation Fund (the fund), is registered under the Investment Company Act of 1940 (the 1940 Act) as a diversified, open-end management investment company. The fund seeks long-term capital appreciation by investing primarily in common stocks. It may also hold fixed-income and other securities to help preserve principal value. The fund has three classes of shares: the Capital Appreciation Fund original share class, referred to in this report as the Investor Class, offered since June 30, 1986; the Capital Appreciation Fund–Advisor Class (Advisor Class), offered since December 31, 2004; and the Capital Appreciation Fund–I Class (I Class), offered since December 17, 2015. Advisor Class shares are sold only through unaffiliated brokers and other unaffiliated financial intermediaries. I Class shares generally are available only to investors meeting a $1,000,000 minimum investment or certain other criteria. The Advisor Class operates under a Board-approved Rule 12b-1 plan pursuant to which the class compensates financial intermediaries for distribution, shareholder servicing, and/or certain administrative services; the Investor and I Classes do not pay Rule 12b-1 fees. Each class has exclusive voting rights on matters related solely to that class; separate voting rights on matters that relate to all classes; and, in all other respects, the same rights and obligations as the other classes.
NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES
Basis of Preparation The fund is an investment company and follows accounting and reporting guidance in the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946 (ASC 946). The accompanying financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (GAAP), including, but not limited to, ASC 946. GAAP requires the use of estimates made by management. Management believes that estimates and valuations are appropriate; however, actual results may differ from those estimates, and the valuations reflected in the accompanying financial statements may differ from the value ultimately realized upon sale or maturity.
Investment Transactions, Investment Income, and Distributions Income and expenses are recorded on the accrual basis. Premiums and discounts on debt securities are amortized for financial reporting purposes. Paydown gains and losses are recorded as an adjustment to interest income. Dividends received from mutual fund investments are reflected as dividend income; capital gain distributions are reflected as realized gain/loss. Dividend income and capital gain distributions are recorded on the ex-dividend date. Income tax-related interest and penalties, if incurred, would be recorded as income tax expense. Investment transactions are accounted for on the trade date. Realized gains and losses are reported on the identified cost basis. Distributions to shareholders are recorded on the ex-dividend date. Distributions from REITs are initially recorded as dividend income and, to the extent such represent a return of capital or capital gain for tax purposes, are reclassified when such information becomes available. Income distributions are declared and paid by each class annually. Capital gain distributions, if any, are generally declared and paid by the fund annually.
Currency Translation Assets, including investments, and liabilities denominated in foreign currencies are translated into U.S. dollar values each day at the prevailing exchange rate, using the mean of the bid and asked prices of such currencies against U.S. dollars as quoted by a major bank. Purchases and sales of securities, income, and expenses are translated into U.S. dollars at the prevailing exchange rate on the date of the transaction. The effect of changes in foreign currency exchange rates on realized and unrealized security gains and losses is reflected as a component of security gains and losses.
Class Accounting Shareholder servicing, prospectus, and shareholder report expenses incurred by each class are charged directly to the class to which they relate. Expenses common to all classes, investment income, and realized and unrealized gains and losses are allocated to the classes based upon the relative daily net assets of each class. The Advisor Class pays distribution, shareholder servicing, and/or certain administrative expenses in the form of Rule 12b-1 fees, in an amount not exceeding 0.25% of the class’s average daily net assets.
Rebates Subject to best execution, the fund may direct certain security trades to brokers who have agreed to rebate a portion of the related brokerage commission to the fund in cash. Commission rebates are reflected as realized gain on securities in the accompanying financial statements and totaled $163,000 for the year ended December 31, 2015.
New Accounting Guidance In May 2015, FASB issued ASU No. 2015-07, Fair Value Measurement (Topic 820), Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent). The ASU removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient and amends certain disclosure requirements for such investments. The ASU is effective for interim and annual reporting periods beginning after December 15, 2015. Adoption will have no effect on the fund’s net assets or results of operations.
NOTE 2 - VALUATION
The fund’s financial instruments are valued and each class’s net asset value (NAV) per share is computed at the close of the New York Stock Exchange (NYSE), normally 4 p.m. ET, each day the NYSE is open for business.
Fair Value The fund’s financial instruments are reported at fair value, which GAAP defines as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The T. Rowe Price Valuation Committee (the Valuation Committee) has been established by the fund’s Board of Trustees (the Board) to ensure that financial instruments are appropriately priced at fair value in accordance with GAAP and the 1940 Act. Subject to oversight by the Board, the Valuation Committee develops and oversees pricing-related policies and procedures and approves all fair value determinations. Specifically, the Valuation Committee establishes procedures to value securities; determines pricing techniques, sources, and persons eligible to effect fair value pricing actions; oversees the selection, services, and performance of pricing vendors; oversees valuation-related business continuity practices; and provides guidance on internal controls and valuation-related matters. The Valuation Committee reports to the Board and has representation from legal, portfolio management and trading, operations, risk management, and the fund’s treasurer.
Various valuation techniques and inputs are used to determine the fair value of financial instruments. GAAP establishes the following fair value hierarchy that categorizes the inputs used to measure fair value:
Level 1 – quoted prices (unadjusted) in active markets for identical financial instruments that the fund can access at the reporting date
Level 2 – inputs other than Level 1 quoted prices that are observable, either directly or indirectly (including, but not limited to, quoted prices for similar financial instruments in active markets, quoted prices for identical or similar financial instruments in inactive markets, interest rates and yield curves, implied volatilities, and credit spreads)
Level 3 – unobservable inputs
Observable inputs are developed using market data, such as publicly available information about actual events or transactions, and reflect the assumptions that market participants would use to price the financial instrument. Unobservable inputs are those for which market data are not available and are developed using the best information available about the assumptions that market participants would use to price the financial instrument. GAAP requires valuation techniques to maximize the use of relevant observable inputs and minimize the use of unobservable inputs. When multiple inputs are used to derive fair value, the financial instrument is assigned to the level within the fair value hierarchy based on the lowest-level input that is significant to the fair value of the financial instrument. Input levels are not necessarily an indication of the risk or liquidity associated with financial instruments at that level but rather the degree of judgment used in determining those values.
Valuation Techniques Equity securities listed or regularly traded on a securities exchange or in the over-the-counter (OTC) market are valued at the last quoted sale price or, for certain markets, the official closing price at the time the valuations are made. OTC Bulletin Board securities are valued at the mean of the closing bid and asked prices. A security that is listed or traded on more than one exchange is valued at the quotation on the exchange determined to be the primary market for such security. Listed securities not traded on a particular day are valued at the mean of the closing bid and asked prices for domestic securities and the last quoted sale or closing price for international securities.
For valuation purposes, the last quoted prices of non-U.S. equity securities may be adjusted to reflect the fair value of such securities at the close of the NYSE. If the fund determines that developments between the close of a foreign market and the close of the NYSE will, in its judgment, materially affect the value of some or all of its portfolio securities, the fund will adjust the previous quoted prices to reflect what it believes to be the fair value of the securities as of the close of the NYSE. In deciding whether it is necessary to adjust quoted prices to reflect fair value, the fund reviews a variety of factors, including developments in foreign markets, the performance of U.S. securities markets, and the performance of instruments trading in U.S. markets that represent foreign securities and baskets of foreign securities. The fund may also fair value securities in other situations, such as when a particular foreign market is closed but the fund is open. The fund uses outside pricing services to provide it with quoted prices and information to evaluate or adjust those prices. The fund cannot predict how often it will use quoted prices and how often it will determine it necessary to adjust those prices to reflect fair value. As a means of evaluating its security valuation process, the fund routinely compares quoted prices, the next day’s opening prices in the same markets, and adjusted prices.
Actively traded equity securities listed on a domestic exchange generally are categorized in Level 1 of the fair value hierarchy. Non-U.S. equity securities generally are categorized in Level 2 of the fair value hierarchy despite the availability of quoted prices because, as described above, the fund evaluates and determines whether those quoted prices reflect fair value at the close of the NYSE or require adjustment. OTC Bulletin Board securities, certain preferred securities, and equity securities traded in inactive markets generally are categorized in Level 2 of the fair value hierarchy.
Debt securities generally are traded in the OTC market. Securities with remaining maturities of one year or more at the time of acquisition are valued at prices furnished by dealers who make markets in such securities or by an independent pricing service, which considers the yield or price of bonds of comparable quality, coupon, maturity, and type, as well as prices quoted by dealers who make markets in such securities. Generally, debt securities are categorized in Level 2 of the fair value hierarchy; however, to the extent the valuations include significant unobservable inputs, the securities would be categorized in Level 3.
Investments in mutual funds are valued at the mutual fund’s closing NAV per share on the day of valuation and are categorized in Level 1 of the fair value hierarchy. Listed options, and OTC options with a listed equivalent, are valued at the mean of the closing bid and asked prices and generally are categorized in Level 2 of the fair value hierarchy. Assets and liabilities other than financial instruments, including short-term receivables and payables, are carried at cost, or estimated realizable value, if less, which approximates fair value.
Thinly traded financial instruments and those for which the above valuation procedures are inappropriate or are deemed not to reflect fair value are stated at fair value as determined in good faith by the Valuation Committee. The objective of any fair value pricing determination is to arrive at a price that could reasonably be expected from a current sale. Financial instruments fair valued by the Valuation Committee are primarily private placements, restricted securities, warrants, rights, and other securities that are not publicly traded.
Subject to oversight by the Board, the Valuation Committee regularly makes good faith judgments to establish and adjust the fair valuations of certain securities as events occur and circumstances warrant. For instance, in determining the fair value of an equity investment with limited market activity, such as a private placement or a thinly traded public company stock, the Valuation Committee considers a variety of factors, which may include, but are not limited to, the issuer’s business prospects, its financial standing and performance, recent investment transactions in the issuer, new rounds of financing, negotiated transactions of significant size between other investors in the company, relevant market valuations of peer companies, strategic events affecting the company, market liquidity for the issuer, and general economic conditions and events. In consultation with the investment and pricing teams, the Valuation Committee will determine an appropriate valuation technique based on available information, which may include both observable and unobservable inputs. The Valuation Committee typically will afford greatest weight to actual prices in arm’s length transactions, to the extent they represent orderly transactions between market participants, transaction information can be reliably obtained, and prices are deemed representative of fair value. However, the Valuation Committee may also consider other valuation methods such as market-based valuation multiples; a discount or premium from market value of a similar, freely traded security of the same issuer; or some combination. Fair value determinations are reviewed on a regular basis and updated as information becomes available, including actual purchase and sale transactions of the issue. Because any fair value determination involves a significant amount of judgment, there is a degree of subjectivity inherent in such pricing decisions, and fair value prices determined by the Valuation Committee could differ from those of other market participants. Depending on the relative significance of unobservable inputs, including the valuation technique(s) used, fair valued securities may be categorized in Level 2 or 3 of the fair value hierarchy.
Valuation Inputs The following table summarizes the fund’s financial instruments, based on the inputs used to determine their fair values on December 31, 2015:
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx50x1.jpg)
There were no material transfers between Levels 1 and 2 during the year ended December 31, 2015.
NOTE 3 - DERIVATIVE INSTRUMENTS
During the year ended December 31, 2015, the fund invested in derivative instruments. As defined by GAAP, a derivative is a financial instrument whose value is derived from an underlying security price, foreign exchange rate, interest rate, index of prices or rates, or other variable; it requires little or no initial investment and permits or requires net settlement. The fund invests in derivatives only if the expected risks and rewards are consistent with its investment objectives, policies, and overall risk profile, as described in its prospectus and Statement of Additional Information. The fund may use derivatives for a variety of purposes, such as seeking to hedge against declines in principal value, increase yield, invest in an asset with greater efficiency and at a lower cost than is possible through direct investment, or to adjust credit exposure. The risks associated with the use of derivatives are different from, and potentially much greater than, the risks associated with investing directly in the instruments on which the derivatives are based. The fund at all times maintains sufficient cash reserves, liquid assets, or other SEC-permitted asset types to cover its settlement obligations under open derivative contracts.
The fund values its derivatives at fair value, as described in Note 2, and recognizes changes in fair value currently in its results of operations. Accordingly, the fund does not follow hedge accounting, even for derivatives employed as economic hedges. Generally, the fund accounts for its derivatives on a gross basis. It does not offset the fair value of derivative liabilities against the fair value of derivative assets on its financial statements, nor does it offset the fair value of derivative instruments against the right to reclaim or obligation to return collateral. As of December 31, 2015, the fund held equity derivatives with a fair value of $77,631,000, included in Written Options on the accompanying Statement of Assets and Liabilities.
Additionally, the amount of gains and losses on derivative instruments recognized in fund earnings during the year ended December 31, 2015, and the related location on the accompanying Statement of Operations is summarized in the following table by primary underlying risk exposure:
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx51x1.jpg)
Counterparty Risk and Collateral The fund invests in derivatives in various markets, which expose it to differing levels of counterparty risk. Counterparty risk on exchange-traded and centrally cleared derivative contracts, such as futures, exchange-traded options, and centrally cleared swaps, is minimal because the clearinghouse provides protection against counterparty defaults.
Derivatives, such as bilateral swaps, forward currency exchange contracts, and OTC options, that are transacted and settle directly with a counterparty (bilateral derivatives) expose the fund to greater counterparty risk. To mitigate this risk, the fund has entered into master netting arrangements (MNAs) with certain counterparties that permit net settlement under specified conditions and, for certain counterparties, also provide collateral agreements. MNAs may be in the form of International Swaps and Derivatives Association master agreements (ISDAs) or foreign exchange letter agreements (FX letters).
MNAs govern the ability to offset amounts the fund owes a counterparty against amounts the counterparty owes the fund (net settlement). Both ISDAs and FX letters generally allow net settlement in the event of contract termination and permit termination by either party prior to maturity upon the occurrence of certain stated events, such as failure to pay or bankruptcy. In addition, ISDAs specify other events, the occurrence of which would allow one of the parties to terminate. For example, a downgrade in credit rating of a counterparty would allow the fund to terminate while a decline in the fund’s net assets of more than a certain percentage would allow the counterparty to terminate. Upon termination, all bilateral derivatives with that counterparty would be liquidated and a net amount settled. ISDAs typically include collateral agreements whereas FX letters do not. Collateral requirements are determined based on the net aggregate unrealized gain or loss on all bilateral derivatives with each counterparty, subject to minimum transfer amounts that typically range from $100,000 to $250,000. Any additional collateral required due to changes in security values is transferred the next business day.
Collateral may be in the form of cash or debt securities issued by the U.S. government or related agencies. Cash and currencies posted by the fund are reflected as cash deposits in the accompanying financial statements and generally are restricted from withdrawal by the fund; securities posted by the fund are so noted in the accompanying Portfolio of Investments; both remain in the fund’s assets. Collateral pledged by counterparties is not included in the fund’s assets because the fund does not obtain effective control over those assets. For bilateral derivatives, collateral posted or received by the fund is held in a segregated account by the fund’s custodian. As of December 31, 2015, no collateral was pledged by either the fund or counterparties for bilateral derivatives. As of As of December 31, 2015, no margin had been posted by the fund for exchange-traded and/or centrally cleared derivatives.
Forward Currency Exchange Contracts The fund is subject to foreign currency exchange rate risk in the normal course of pursuing its investment objectives. It uses forward currency exchange contracts (forwards) primarily to protect its non-U.S. dollar-denominated securities from adverse currency movements relative to the U.S. dollar. A forward involves an obligation to purchase or sell a fixed amount of a specific currency on a future date at a price set at the time of the contract. Although certain forwards may be settled by exchanging only the net gain or loss on the contract, most forwards are settled with the exchange of the underlying currencies in accordance with the specified terms. Forwards are valued at the unrealized gain or loss on the contract, which reflects the net amount the fund either is entitled to receive or obligated to deliver, as measured by the difference between the forward exchange rates at the date of entry into the contract and the forward rates at the reporting date. Appreciated forwards are reflected as assets and depreciated forwards are reflected as liabilities on the accompanying Statement of Assets and Liabilities. Risks related to the use of forwards include the possible failure of counterparties to meet the terms of the agreements; that anticipated currency movements will not occur, thereby reducing the fund’s total return; and the potential for losses in excess of the fund’s initial investment. During the year ended December 31, 2015, the volume of the fund’s activity in forwards, based on underlying notional amounts, was generally less than 1% of net assets.
Futures Contracts The fund is subject to equity price risk in the normal course of pursuing its investment objectives and uses futures contracts to help manage such risk. The fund may enter into futures contracts to manage exposure to interest rates, security prices, foreign currencies, and credit quality; as an efficient means of adjusting exposure to all or part of a target market; to enhance income; as a cash management tool; or to adjust credit exposure. A futures contract provides for the future sale by one party and purchase by another of a specified amount of a specific underlying financial instrument at an agreed-upon price, date, time, and place. The fund currently invests only in exchange-traded futures, which generally are standardized as to maturity date, underlying financial instrument, and other contract terms. Payments are made or received by the fund each day to settle daily fluctuations in the value of the contract (variation margin), which reflect changes in the value of the underlying financial instrument. Variation margin is recorded as unrealized gain or loss until the contract is closed. The value of a futures contract included in net assets is the amount of unsettled variation margin; net variation margin receivable is reflected as an asset, and net variation margin payable is reflected as a liability on the accompanying Statement of Assets and Liabilities. Risks related to the use of futures contracts include possible illiquidity of the futures markets, contract prices that can be highly volatile and imperfectly correlated to movements in hedged security values, and potential losses in excess of the fund’s initial investment. During the year ended December 31, 2015, the volume of the fund’s activity in futures, based on underlying notional amounts, was generally between 0% and 2% of net assets.
Options The fund is subject to equity price risk in the normal course of pursuing its investment objectives and uses options to help manage such risk. The fund may use options to manage exposure to security prices, interest rates, foreign currencies, and credit quality; as an efficient means of adjusting exposure to all or a part of a target market; to enhance income; as a cash management tool; or to adjust credit exposure. Options are included in net assets at fair value, purchased options are included in Investments in Securities, and written options are separately reflected as a liability on the accompanying Statement of Assets and Liabilities. Premiums on unexercised, expired options are recorded as realized gains or losses; premiums on exercised options are recorded as an adjustment to the proceeds from the sale or cost of the purchase. The difference between the premium and the amount received or paid in a closing transaction is also treated as realized gain or loss. In return for a premium paid, call and put options give the holder the right, but not the obligation, to purchase or sell, respectively, a security at a specified exercise price. Risks related to the use of options include possible illiquidity of the options markets; trading restrictions imposed by an exchange or counterparty; movements in the underlying asset values and, for written options, potential losses in excess of the fund’s initial investment. During the year ended December 31, 2015, the volume of the fund’s activity in options, based on underlying notional amounts, was generally between 5% and 11% of net assets. Transactions in written options and related premiums received during the year ended December 31, 2015, were as follows:
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx55x1.jpg)
NOTE 4 - OTHER INVESTMENT TRANSACTIONS
Consistent with its investment objective, the fund engages in the following practices to manage exposure to certain risks and/or to enhance performance. The investment objective, policies, program, and risk factors of the fund are described more fully in the fund’s prospectus and Statement of Additional Information.
Noninvestment-Grade Debt At December 31, 2015, approximately 16% of the fund’s net assets were invested, either directly or through its investment in T. Rowe Price institutional funds, in noninvestment-grade debt, including “high yield” or “junk” bonds or leveraged loans. The noninvestment-grade debt market may experience sudden and sharp price swings due to a variety of factors, including changes in economic forecasts, stock market activity, large sustained sales by major investors, a high-profile default, or a change in market sentiment. These events may decrease the ability of issuers to make principal and interest payments and adversely affect the liquidity or value, or both, of such securities.
Restricted Securities The fund may invest in securities that are subject to legal or contractual restrictions on resale. Prompt sale of such securities at an acceptable price may be difficult and may involve substantial delays and additional costs.
Bank Loans The fund may invest in bank loans, which represent an interest in amounts owed by a borrower to a syndication of lenders. Bank loans are generally noninvestment grade and often involve borrowers whose financial condition is troubled or highly leveraged. Bank loans may be in the form of either assignments or participations. A loan assignment transfers all legal, beneficial, and economic rights to the buyer, and transfer typically requires consent of both the borrower and agent. In contrast, a loan participation generally entitles the buyer to receive the cash flows from principal, interest, and any fee payments; however, the seller continues to hold legal title to the loan. As a result, the buyer of a loan participation generally has no direct rights against the borrower and is exposed to credit risk of both the borrower and seller of the participation. Bank loans often have extended settlement periods, usually may be repaid at any time at the option of the borrower, and may require additional principal to be funded at the borrowers’ discretion at a later date (unfunded commitments). Until settlement, the fund maintains liquid assets sufficient to settle its unfunded loan commitments. The fund reflects both the funded portion of a bank loan as well as its unfunded commitment in the Portfolio of Investments. However, to the extent a credit agreement provides no initial funding of a tranche and funding of the full commitment at a future date(s) is at the borrower’s discretion and considered uncertain, no loan is reflected in the Portfolio of Investments until paid.
Securities Lending The fund may lend its securities to approved brokers to earn additional income. Its securities lending activities are administered by a lending agent in accordance with a securities lending agreement. Security loans generally do not have stated maturity dates, and the fund may recall a security at any time. The fund receives collateral in the form of cash or U.S. government securities, valued at 102% to 105% of the value of the securities on loan. Collateral is maintained over the life of the loan in an amount not less than the value of loaned securities; any additional collateral required due to changes in security values is delivered to the fund the next business day. Cash collateral is invested by the lending agent(s) in accordance with investment guidelines approved by fund management. Additionally, the lending agent indemnifies the fund against losses resulting from borrower default. Although risk is mitigated by the collateral and indemnification, the fund could experience a delay in recovering its securities and a possible loss of income or value if the borrower fails to return the securities, collateral investments decline in value, and the lending agent fails to perform. Securities lending revenue consists of earnings on invested collateral and borrowing fees, net of any rebates to the borrower, compensation to the lending agent, and other administrative costs. In accordance with GAAP, investments made with cash collateral are reflected in the accompanying financial statements, but collateral received in the form of securities is not. At December 31, 2015, there were no securities on loan.
Other Purchases and sales of portfolio securities other than short-term securities aggregated $14,211,686,000 and $15,357,762,000, respectively, for the year ended December 31, 2015.
NOTE 5 - FEDERAL INCOME TAXES
No provision for federal income taxes is required since the fund intends to continue to qualify as a regulated investment company under Subchapter M of the Internal Revenue Code and distribute to shareholders all of its taxable income and gains. Distributions determined in accordance with federal income tax regulations may differ in amount or character from net investment income and realized gains for financial reporting purposes. Financial reporting records are adjusted for permanent book/tax differences to reflect tax character but are not adjusted for temporary differences.
The fund files U.S. federal, state, and local tax returns as required. The fund’s tax returns are subject to examination by the relevant tax authorities until expiration of the applicable statute of limitations, which is generally three years after the filing of the tax return but which can be extended to six years in certain circumstances. Tax returns for open years have incorporated no uncertain tax positions that require a provision for income taxes.
Reclassifications to paid-in capital relate primarily to redemptions in kind or a tax practice that treats a portion of the proceeds from each redemption of capital shares as a distribution of taxable net investment income. For the year ended December 31,2015, the following reclassifications were recorded to reflect tax character (there was no impact on results of operations or net assets):
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx57x1.jpg)
Distributions during the years ended December 31, 2015 and December 31, 2014, were characterized for tax purposes as follows:
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx58x1.jpg)
At December 31, 2015, the tax-basis cost of investments and components of net assets were as follows:
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx58x2.jpg)
The difference between book-basis and tax-basis net unrealized appreciation (depreciation) is attributable to the deferral of losses from wash sales for tax purposes. The fund intends to retain realized gains to the extent of available capital loss carryforwards. Net realized capital losses may be carried forward indefinitely to offset future realized capital gains. All or a portion of the capital loss carryforwards may be from losses realized between November 1 and the fund’s fiscal year-end, which are deferred for tax purposes until the subsequent year but recognized for financial reporting purposes in the year realized. In accordance with federal tax laws applicable to investment companies, specified net losses realized between November 1 and December 31 are not recognized for tax purposes until the subsequent year (late-year ordinary loss deferrals); however, such losses are recognized for financial reporting purposes in the year realized.
NOTE 6 - RELATED PARTY TRANSACTIONS
The fund is managed by T. Rowe Price Associates, Inc. (Price Associates), a wholly owned subsidiary of T. Rowe Price Group, Inc. (Price Group). The investment management agreement between the fund and Price Associates provides for an annual investment management fee, which is computed daily and paid monthly. The fee consists of an individual fund fee, equal 0.30% of the fund’s average daily net assets, and a group fee. The group fee rate is calculated based on the combined net assets of certain mutual funds sponsored by Price Associates (the group) applied to a graduated fee schedule, with rates ranging from 0.48% for the first $1 billion of assets to 0.275% for assets in excess of $400 billion. The fund’s group fee is determined by applying the group fee rate to the fund’s average daily net assets. At December 31, 2015, the effective annual group fee rate was 0.29%.
The I Class is subject to an operating expense limitation (I Class limit) pursuant to which Price Associates is contractually required to pay all operating expenses of the I Class, excluding management fees, interest, borrowing-related expenses, taxes, brokerage commissions, and extraordinary expenses, to the extent such operating expenses, on an annualized basis, exceed 0.05% of average net assets. This agreement will continue until April 30, 2018, and may be renewed, revised or revoked only with approval of the fund’s Board. The I Class is required to repay Price Associates for expenses previously paid to the extent the class’s net assets grow or expenses decline sufficiently to allow repayment without causing the class’s operating expenses to exceed the I Class limit. However, no repayment will be made more than three years after the date of a payment or waiver. Pursuant to this agreement, less than $1,000 of expenses were waived/paid by Price Associates during the year ended December 31, 2015 and remain subject to repayment by the fund.
In addition, the fund has entered into service agreements with Price Associates and two wholly owned subsidiaries of Price Associates (collectively, Price). Price Associates provides certain accounting and administrative services to the fund. T. Rowe Price Services, Inc., provides shareholder and administrative services in its capacity as the fund’s transfer and dividend-disbursing agent. T. Rowe Price Retirement Plan Services, Inc., provides subaccounting and recordkeeping services for certain retirement accounts invested in the Investor Class. For the year ended December 31, 2015, expenses incurred pursuant to these service agreements were $145,000 for Price Associates; $6,090,000 for T. Rowe Price Services, Inc.; and $2,209,000 for T. Rowe Price Retirement Plan Services, Inc. The total amount payable at period-end pursuant to these service agreements is reflected as Due to Affiliates in the accompanying financial statements.
The fund may invest in the T. Rowe Price Reserve Investment Fund, the T. Rowe Price Government Reserve Investment Fund, or the T. Rowe Price Short-Term Reserve Fund (collectively, the Price Reserve Investment Funds), open-end management investment companies managed by Price Associates and considered affiliates of the fund. The Price Reserve Investment Funds are offered as short-term investment options to mutual funds, trusts, and other accounts managed by Price Associates or its affiliates and are not available for direct purchase by members of the public. The Price Reserve Investment Funds pay no investment management fees.
The fund may also invest in certain other T. Rowe Price funds (Price Funds) as a means of gaining efficient and cost-effective exposure to certain markets. The fund does not invest for the purpose of exercising management or control; however, investments by the fund may represent a significant portion of an underlying Price Fund’s net assets. Each underlying Price Fund is an open-end management investment company managed by Price Associates and is considered an affiliate of the fund. To ensure that the fund does not incur duplicate management fees (paid by the underlying Price Fund(s) and the fund), Price Associates has agreed to permanently waive a portion of its management fee charged to the fund in an amount sufficient to fully offset that portion of management fees paid by each underlying Price Fund related to the fund’s investment therein. Annual management fee rates and amounts waived related to investments in the underlying Price Fund(s) for the year ended December 31, 2015, are as follows:
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx60x1.jpg)
As of December 31, 2015, T. Rowe Price Group, Inc., or its wholly owned subsidiaries owned 10,020 shares of the I Class, aggregating less than 1% of the fund’s net assets.
Report of Independent Registered Public Accounting Firm |
To the Board of Trustees and Shareholders of
T. Rowe Price Capital Appreciation Fund
In our opinion, the accompanying statement of assets and liabilities, including the portfolio of investments, and the related statements of operations and of changes in net assets and the financial highlights present fairly, in all material respects, the financial position of T. Rowe Price Capital Appreciation Fund (the “Fund”) at December 31, 2015, the results of its operations, the changes in its net assets and the financial highlights for each of the periods indicated therein, in conformity with accounting principles generally accepted in the United States of America. These financial statements and financial highlights (hereafter referred to as “financial statements”) are the responsibility of the Fund’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits of these financial statements in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits, which included confirmation of securities at December 31, 2015 by correspondence with the custodian and brokers, and confirmation of the underlying funds by correspondence with the transfer agent, provide a reasonable basis for our opinion.
PricewaterhouseCoopers LLP
Baltimore, Maryland
February 17, 2016
Tax Information (Unaudited) for the Tax Year Ended 12/31/15 |
We are providing this information as required by the Internal Revenue Code. The amounts shown may differ from those elsewhere in this report because of differences between tax and financial reporting requirements.
The fund’s distributions to shareholders included:
● | $505,596,000 from short-term capital gains |
● | $1,523,709,000 from long-term capital gains, subject to a long-term capital gains tax rate of not greater than 20%. |
For taxable non-corporate shareholders, $220,399,000 of the fund’s income represents qualified dividend income subject to a long-term capital gains tax rate of not greater than 20%.
For corporate shareholders, $181,496,000 of the fund’s income qualifies for the dividends-received deduction.
Information on Proxy Voting Policies, Procedures, and Records |
A description of the policies and procedures used by T. Rowe Price funds and portfolios to determine how to vote proxies relating to portfolio securities is available in each fund’s Statement of Additional Information. You may request this document by calling 1-800-225-5132 or by accessing the SEC’s website, sec.gov.
The description of our proxy voting policies and procedures is also available on our website, troweprice.com. To access it, click on the words “Social Responsibility” at the top of our corporate homepage. Next, click on the words “Conducting Business Responsibly” on the left side of the page that appears. Finally, click on the words “Proxy Voting Policies” on the left side of the page that appears.
Each fund’s most recent annual proxy voting record is available on our website and through the SEC’s website. To access it through our website, follow the above directions to reach the “Conducting Business Responsibly” page. Click on the words “Proxy Voting Records” on the left side of that page, and then click on the “View Proxy Voting Records” link at the bottom of the page that appears.
How to Obtain Quarterly Portfolio Holdings |
The fund files a complete schedule of portfolio holdings with the Securities and Exchange Commission for the first and third quarters of each fiscal year on Form N-Q. The fund’s Form N-Q is available electronically on the SEC’s website (sec.gov); hard copies may be reviewed and copied at the SEC’s Public Reference Room, 100 F St. N.E., Washington, DC 20549. For more information on the Public Reference Room, call 1-800-SEC-0330.
About the Fund’s Trustees and Officers |
Your fund is overseen by a Board of Trustees (Board) that meets regularly to review a wide variety of matters affecting or potentially affecting the fund, including performance, investment programs, compliance matters, advisory fees and expenses, service providers, and business and regulatory affairs. The Board elects the fund’s officers, who are listed in the final table. At least 75% of the Board’s members are independent of T. Rowe Price Associates, Inc. (T. Rowe Price), and its affiliates; “inside” or “interested” trustees are employees or officers of T. Rowe Price. The business address of each trustee and officer is 100 East Pratt Street, Baltimore, Maryland 21202. The Statement of Additional Information includes additional information about the fund trustees and is available without charge by calling a T. Rowe Price representative at 1-800-638-5660.
Independent Trustees
Name | | |
(Year of Birth) | | |
Year Elected* | | |
[Number of T. Rowe Price | | Principal Occupation(s) and Directorships of Public Companies and |
Portfolios Overseen] | | Other Investment Companies During the Past Five Years |
| | |
William R. Brody, M.D., Ph.D. | | President and Trustee, Salk Institute for Biological Studies (2009 to |
(1944) | | present); Director, BioMed Realty Trust (2013 to present); Director, |
2009 | | Novartis, Inc. (2009 to 2014); Director, IBM (2007 to present) |
[181] | | |
| | |
Anthony W. Deering | | Chairman, Exeter Capital, LLC, a private investment firm (2004 to |
(1945) | | present); Director, Brixmor Real Estate Investment Trust (2012 to |
2001 | | present); Director and Advisory Board Member, Deutsche Bank North |
[181] | | America (2004 to present); Director, Under Armour (2008 to present); |
| | Director, Vornado Real Estate Investment Trust (2004 to 2012) |
| | |
Bruce W. Duncan | | President, Chief Executive Officer, and Director, First Industrial |
(1951) | | Realty Trust, an owner and operator of industrial properties |
2013 | | (2009 to present); Chairman of the Board (2005 to present) and |
[181] | | Director (1999 to present), Starwood Hotels & Resorts, a hotel and |
| | leisure company |
| | |
Robert J. Gerrard, Jr. | | Chairman of Compensation Committee and Director, Syniverse |
(1952) | | Holdings, Inc., a provider of wireless voice and data services for |
2012 | | telecommunications companies (2008 to 2011); Advisory Board |
[181] | | Member, Pipeline Crisis/Winning Strategies, a collaborative |
| | working to improve opportunities for young African Americans |
| | (1997 to present) |
| | |
Paul F. McBride | | Former Company Officer and Senior Vice President, Human |
(1956) | | Resources and Corporate Initiatives, Black & Decker Corporation |
2013 | | (2004 to 2010) |
[181] | | |
| | |
Cecilia E. Rouse, Ph.D. | | Dean, Woodrow Wilson School (2012 to present); Professor and |
(1963) | | Researcher, Princeton University (1992 to present); Director, MDRC, a |
2012 | | nonprofit education and social policy research organization (2011 to |
[181] | | present); Member, National Academy of Education (2010 to present); |
| | Research Associate, National Bureau of Economic Research’s Labor |
| | Studies Program (2011 to present); Member, President’s Council of |
| | Economic Advisers (2009 to 2011); Chair of Committee on the Status |
| | of Minority Groups in the Economic Profession, American Economic |
| | Association (2012 to present) |
| | |
John G. Schreiber | | Owner/President, Centaur Capital Partners, Inc., a real estate |
(1946) | | investment company (1991 to present); Cofounder and Partner, |
2001 | | Blackstone Real Estate Advisors, L.P. (1992 to present); Director, |
[181] | | General Growth Properties, Inc. (2010 to 2013); Director, Blackstone |
| | Mortgage Trust, a real estate financial company (2012 to present); |
| | Director and Chairman of the Board, Brixmor Property Group, Inc. |
| | (2013 to present); Director, Hilton Worldwide (2013 to present); |
| | Director, Hudson Pacific Properties (2014 to present) |
| | |
Mark R. Tercek | | President and Chief Executive Officer, The Nature Conservancy |
(1957) | | (2008 to present) |
2009 | | |
[181] | | |
*Each independent trustee serves until retirement, resignation, or election of a successor.
Inside Trustees
Name | | |
(Year of Birth) | | |
Year Elected* | | |
[Number of T. Rowe Price | | Principal Occupation(s) and Directorships of Public Companies and |
Portfolios Overseen] | | Other Investment Companies During the Past Five Years |
| | |
Edward C. Bernard | | Director and Vice President, T. Rowe Price; Vice Chairman of the |
(1956) | | Board, Director, and Vice President, T. Rowe Price Group, Inc.; |
2006 | | Chairman of the Board, Director, and President, T. Rowe Price |
[181] | | Investment Services, Inc.; Chairman of the Board and Director, |
| | T. Rowe Price Retirement Plan Services, Inc., and T. Rowe Price |
| | Services, Inc.; Chairman of the Board, Chief Executive Officer, |
| | Director, and President, T. Rowe Price International and T. Rowe |
| | Price Trust Company; Chairman of the Board, all funds |
| | |
Brian C. Rogers, CFA, CIC | | Chief Investment Officer, Director, and Vice President, T. Rowe Price; |
(1955) | | Chairman of the Board, Chief Investment Officer, Director, and Vice |
2006 | | President, T. Rowe Price Group, Inc.; Vice President, T. Rowe Price |
[127] | | Trust Company |
*Each inside trustee serves until retirement, resignation, or election of a successor.
Officers
Name (Year of Birth) | | |
Position Held With Capital Appreciation Fund | | Principal Occupation(s) |
| | |
Darrell N. Braman (1963) | | Vice President, Price Hong Kong, Price |
Vice President | | Singapore, T. Rowe Price, T. Rowe Price Group, |
| | Inc., T. Rowe Price International, T. Rowe Price |
| | Investment Services, Inc., and T. Rowe Price |
| | Services, Inc. |
| | |
Ryan N. Burgess, CFA (1974) | | Vice President, T. Rowe Price and T. Rowe Price |
Vice President | | Group, Inc. |
| | |
Jon M. Friar (1982) | | Vice President, T. Rowe Price and T. Rowe Price |
Vice President | | Group, Inc.; formerly, summer intern, T. Rowe |
| | Price (to 2011) |
| | |
John R. Gilner (1961) | | Chief Compliance Officer and Vice President, |
Chief Compliance Officer | | T. Rowe Price; Vice President, T. Rowe Price |
| | Group, Inc., and T. Rowe Price Investment |
| | Services, Inc. |
| | |
David R. Giroux, CFA (1975) | | Vice President, T. Rowe Price, T. Rowe Price |
President | | Group, Inc., and T. Rowe Price Trust Company |
| | |
Paul D. Greene II (1978) | | Vice President, T. Rowe Price and T. Rowe Price |
Vice President | | Group, Inc. |
| | |
Dominic Janssens (1965) | | Vice President, T. Rowe Price, T. Rowe Price |
Vice President | | Group, Inc., and T. Rowe Price Trust Company |
| | |
Nina P. Jones, CPA (1980) | | Vice President, T. Rowe Price and T. Rowe Price |
Vice President | | Group, Inc. |
| | |
Vidya Kadiyam (1980) | | Vice President, T. Rowe Price and T. Rowe Price |
Vice President | | Group, Inc. |
| | |
Steven D. Krichbaum (1977) | | Vice President, T. Rowe Price and T. Rowe Price |
Vice President | | Group, Inc. |
| | |
Paul J. Krug, CPA (1964) | | Vice President, T. Rowe Price, T. Rowe Price |
Vice President | | Group, Inc., and T. Rowe Price Trust Company |
| | |
John D. Linehan, CFA (1965) | | Vice President, T. Rowe Price, T. Rowe Price |
Vice President | | Group, Inc., and T. Rowe Price Trust Company |
| | |
Patricia B. Lippert (1953) | | Assistant Vice President, T. Rowe Price and |
Secretary | | T. Rowe Price Investment Services, Inc. |
| | |
Paul M. Massaro, CFA (1975) | | Vice President, T. Rowe Price, T. Rowe Price |
Vice President | | Group, Inc., and T. Rowe Price Trust Company |
| | |
Catherine D. Mathews (1963) | | Vice President, T. Rowe Price, T. Rowe Price |
Treasurer and Vice President | | Group, Inc., and T. Rowe Price Trust Company |
| | |
Sudhir Nanda, Ph.D., CFA (1959) | | Vice President, T. Rowe Price and T. Rowe Price |
Vice President | | Group, Inc. |
| | |
David Oestreicher (1967) | | Director, Vice President, and Secretary, |
Vice President | | T. Rowe Price Investment Services, Inc., T. Rowe |
| | Price Retirement Plan Services, Inc., T. Rowe |
| | Price Services, Inc., and T. Rowe Price Trust |
| | Company; Chief Legal Officer, Vice President, |
| | and Secretary, T. Rowe Price Group, Inc.; Vice |
| | President and Secretary, T. Rowe Price and |
| | T. Rowe Price International; Vice President, |
| | Price Hong Kong and Price Singapore |
| | |
Robert T. Quinn, Jr. (1972) | | Vice President, T. Rowe Price and T. Rowe Price |
Vice President | | Group, Inc. |
| | |
John W. Ratzesberger (1975) | | Vice President, T. Rowe Price, T. Rowe Price |
Vice President | | Group, Inc., and T. Rowe Price Trust Company; |
| | formerly, North American Head of Listed |
| | Derivatives Operation, Morgan Stanley |
| | (to 2013) |
| | |
Deborah D. Seidel (1962) | | Vice President, T. Rowe Price, T. Rowe Price |
Vice President | | Group, Inc., T. Rowe Price Investment Services, |
| | Inc., and T. Rowe Price Services, Inc. |
| | |
Farris G. Shuggi (1984) | | Vice President, T. Rowe Price and T. Rowe Price |
Vice President | | Group, Inc. |
| | |
Gabriel Solomon (1977) | | Vice President, T. Rowe Price and T. Rowe Price |
Vice President | | Group, Inc. |
| | |
Taymour R. Tamaddon, CFA (1976) | | Vice President, T. Rowe Price and T. Rowe Price |
Vice President | | Group, Inc. |
| | |
Susan G. Troll, CPA (1966) | | Vice President, T. Rowe Price and T. Rowe Price |
Vice President | | Group, Inc. |
| | |
Tamara P. Wiggs (1979) | | Vice President, T. Rowe Price and T. Rowe Price |
Vice President | | Group, Inc. |
| | |
Jeffrey T. Zoller (1970) | | Vice President, T. Rowe Price, T. Rowe Price |
Vice President | | International, and T. Rowe Price Trust Company |
Unless otherwise noted, officers have been employees of T. Rowe Price or T. Rowe Price International for at least 5 years.
Item 2. Code of Ethics.
The registrant has adopted a code of ethics, as defined in Item 2 of Form N-CSR, applicable to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of this code of ethics is filed as an exhibit to this Form N-CSR. No substantive amendments were approved or waivers were granted to this code of ethics during the period covered by this report.
Item 3. Audit Committee Financial Expert.
The registrant’s Board of Directors/Trustees has determined that Mr. Bruce W. Duncan qualifies as an audit committee financial expert, as defined in Item 3 of Form N-CSR. Mr. Duncan is considered independent for purposes of Item 3 of Form N-CSR.
Item 4. Principal Accountant Fees and Services.
(a) – (d) Aggregate fees billed for the last two fiscal years for professional services rendered to, or on behalf of, the registrant by the registrant’s principal accountant were as follows:
![](https://capedge.com/proxy/N-CSR/0001206774-16-004614/arcaf_ncsrx1x1.jpg)
Audit fees include amounts related to the audit of the registrant’s annual financial statements and services normally provided by the accountant in connection with statutory and regulatory filings. Audit-related fees include amounts reasonably related to the performance of the audit of the registrant’s financial statements and specifically include the issuance of a report on internal controls and, if applicable, agreed-upon procedures related to fund acquisitions. Tax fees include amounts related to services for tax compliance, tax planning, and tax advice. The nature of these services specifically includes the review of distribution calculations and the preparation of Federal, state, and excise tax returns. All other fees include the registrant’s pro-rata share of amounts for agreed-upon procedures in conjunction with service contract approvals by the registrant’s Board of Directors/Trustees.
(e)(1) The registrant’s audit committee has adopted a policy whereby audit and non-audit services performed by the registrant’s principal accountant for the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant require pre-approval in advance at regularly scheduled audit committee meetings. If such a service is required between regularly scheduled audit committee meetings, pre-approval may be authorized by one audit committee member with ratification at the next scheduled audit committee meeting. Waiver of pre-approval for audit or non-audit services requiring fees of a de minimis amount is not permitted.
(2) No services included in (b) – (d) above were approved pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.
(f) Less than 50 percent of the hours expended on the principal accountant’s engagement to audit the registrant’s financial statements for the most recent fiscal year were attributed to work performed by persons other than the principal accountant’s full-time, permanent employees.
(g) The aggregate fees billed for the most recent fiscal year and the preceding fiscal year by the registrant’s principal accountant for non-audit services rendered to the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant were $2,158,000 and $2,283,000, respectively.
(h) All non-audit services rendered in (g) above were pre-approved by the registrant’s audit committee. Accordingly, these services were considered by the registrant’s audit committee in maintaining the principal accountant’s independence.
Item 5. Audit Committee of Listed Registrants.
Not applicable.
Item 6. Investments.
(a) Not applicable. The complete schedule of investments is included in Item 1 of this Form N-CSR.
(b) Not applicable.
Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 8. Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 10. Submission of Matters to a Vote of Security Holders.
Not applicable.
Item 11. Controls and Procedures.
(a) The registrant’s principal executive officer and principal financial officer have evaluated the registrant’s disclosure controls and procedures within 90 days of this filing and have concluded that the registrant’s disclosure controls and procedures were effective, as of that date, in ensuring that information required to be disclosed by the registrant in this Form N-CSR was recorded, processed, summarized, and reported timely.
(b) The registrant’s principal executive officer and principal financial officer are aware of no change in the registrant’s internal control over financial reporting that occurred during the registrant’s second fiscal quarter covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
Item 12. Exhibits.
(a)(1) The registrant’s code of ethics pursuant to Item 2 of Form N-CSR is attached.
(2) Separate certifications by the registrant's principal executive officer and principal financial officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(a) under the Investment Company Act of 1940, are attached.
(3) Written solicitation to repurchase securities issued by closed-end companies: not applicable.
(b) A certification by the registrant's principal executive officer and principal financial officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(b) under the Investment Company Act of 1940, is attached.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
T. Rowe Price Capital Appreciation Fund
| By | /s/ Edward C. Bernard |
| | Edward C. Bernard |
| | Principal Executive Officer |
| |
Date February 17, 2016 | | |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| By | /s/ Edward C. Bernard |
| | Edward C. Bernard |
| | Principal Executive Officer |
| |
Date February 17, 2016 | | |
| |
| |
| By | /s/ Catherine D. Mathews |
| | Catherine D. Mathews |
| | Principal Financial Officer |
| |
Date February 17, 2016 | | |